本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ReShape Lifesciences, Inc.

2.61
+0.22509.45%
成交量:54.57万
成交额:139.06万
市值:621.54万
市盈率:-0.01
高:2.73
开:2.36
低:2.36
收:2.38
数据加载中...
2023/09/28

SEC问询函

Form CORRESP - Correspondence
2023/09/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/22

重要事件披露

Form 8-K - Current report
2023/09/12

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/08/26

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/06/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/16

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/26

重要事件披露

8-K - Current report
2023/04/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/13

重要事件披露

8-K - Current report
2023/03/21

重要事件披露

8-K - Current report
2023/03/17

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/02/15

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

重要事件披露

8-K - Current report
2023/02/03

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/03

SEC问询函

CORRESP [Cover] - Correspondence